Iovance Biotherapeutics, Inc.’s IOVA share price has dipped by 39.12%, which has investors questioning if this is right time to buy.

Iovance Therapeutics’ stock dropped more than 44% on Friday afternoon, a day after the company slashed its 2025 sales ...

Shares of Iovance Biotherapeutics (NASDAQ:IOVA) plummeted 46% following a disappointing first quarter earnings report, which revealed both a miss on revenue expectations and a lowered guidance for the ...